KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,210 | -5.9% | 55 | 0.0% | 0.00% | – |
| Q1 2023 | $2,349 | -11.1% | 55 | 0.0% | 0.00% | – |
| Q4 2022 | $2,641 | +32.0% | 55 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 55 | +34.1% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 41 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |